Number of the records: 1  

Assessment of adiponectin and clinical and metabolic risk factors in patients with NAFLD and metabolic syndrome

  1. SYS0190171
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20230727120823.0
    100
      
    $a 20230727d2018 m y0sloy0103 ba
    101
    0-
    $a eng
    102
      
    $a PL
    200
    1-
    $a Assessment of adiponectin and clinical and metabolic risk factors in patients with NAFLD and metabolic syndrome $f Kupčová V. ... [et al.]
    303
      
    $a Popis urobený z citácie
    463
    -1
    $1 200 1 $a Clin Exp Hepatol $v Suppl. 1 (2018), s. 27-28
    701
    -1
    $3 sllk_un_auth*p0028679 $a Kupčová $b Viera $f 1951- $p 3. interná klinika LF UK a FNsP Bratislava, Nemocnica akademika L. Dérera, Bratislava $4 070
    701
    -1
    $3 sllk_un_auth*p0020569 $a Muchová $b Jana $f 1951- $p Ústav lekárskej chémie, biochémie a klinickej biochémie LFUK, Bratislava $4 070
    701
    -1
    $3 sllk_un_auth*p0061054 $a Bulas $b Jozef $p 1. interná klinika LF UK a UN Bratislava $4 070
    701
    -1
    $3 sllk_un_auth*0026797 $a Potočárová $b Mária $p 1. interná klinika LFUK a UNB, Bratislava $4 070
    701
    -1
    $3 sllk_un_auth*0023010 $a Fedelešová $b Michaela $p 3. interná klinika LF UK a Nemocnica akad. L. Dérera UN Bratislava $4 070
    701
    -1
    $3 sllk_un_auth*p0004460 $a Turecký $b Ladislav $f 1953- $p Ústav lekárskej chémie, biochémie a klinickej biochémie LF UK, Bratislava $4 070
    801
    -0
    $a SK $b BA006 $c 20230727 $g AACR2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.